Myelodysplastic Syndromes (MDS) are a group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy blood cells. MDS is often referred to as a “bone marrow failure disorder”. MDS is primarily a disease of the elderly (most patients are older than age 65), but MDS can affect younger patients as well.
To understand MDS better, visit the MDS Foundation website at www.mds-foundation.org
The MDS Foundation is a global non-profit advocacy organization that for over 25 years has supported patients and their families as well as health care providers in the fields of MDS and its related diseases.
The MDS Foundation supports and educates patients, their communities, and healthcare providers, and contributes to innovative research in the fields of MDS and its related continuum of diseases to better diagnose, control and ultimately cure these diseases.
To find out more, visit www.mds-foundation.org
Acceleron is dedicated to the discovery and development of innovative, life-changing medicines for patients with a wide range of serious and rare diseases. Our research focuses on harnessing the power of the TGF-beta protein superfamily, the target-rich area of biology behind the body’s remarkable capacity for cellular growth and repair. Our mission is to transform the lives of patients with serious and rare diseases.
Visit our website at www.acceleronpharma.com